Exovesicular-Shh Confers Imatinib Resistance by Upregulating Bcl2 Expression in Chronic Myeloid Leukemia with Variant Chromosomes

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2021 Mar 12

PMID 33707419

Citations 3

Authors

Anusha

Hamza Dalal

Sitalakshmi Subramanian

Snijesh V P

Divya A Gowda

Krishnamurthy H

Sharat Damodar

Neha Vyas

Affiliations

Soon will be listed here.

Abstract

Chronic myeloid leukemia (CML) patients with complex chromosomal translocations as well as non-compliant CML patients often demonstrate short-lived responses and poor outcomes on the current therapeutic regimes using Imatinib and its variants. It has been derived so far that leukemic stem cells (LSCs) are responsible for Imatinib resistance and CML progression. Sonic hedgehog (Shh) signaling has been implicated in proliferation of this Imatinib-resistant CD34(+) LSCs. Our work here identifies the molecular mechanism of Shh-mediated mutation-independent Imatinib resistance that is most relevant for treating CML-variants and non-compliant patients. Our results elucidate that while Shh can impart stemness, it also upregulates expression of anti-apoptotic protein-Bcl2. It is the upregulation of Bcl2 that is involved in conferring Imatinib resistance to the CD34(+) LSCs. Sub-toxic doses of Bcl2 inhibitor or Shh inhibitor (<<IC50), when used as adjuvants along with Imatinib, can re-sensitize Shh signaling cells to Imatinib. Our work here highlights the need to molecularly stratify CML patients and implement combinatorial therapy to overcome the current limitations and improve outcomes in CML.

Citing Articles

Real time-PCR a diagnostic tool for reporting copy number variation and relative gene-expression changes in pediatric B-cell acute lymphoblastic leukemia-a pilot study.

Sadaqat Z, Joseph S, Verma C, Muni Reddy J, Prakash A, Thomas T Biol Methods Protoc. 2025; 10(1):bpae098.

PMID: 39802454 PMC: 11717350. DOI: 10.1093/biomethods/bpae098.

The Hedgehog Pathway as a Therapeutic Target in Chronic Myeloid Leukemia.

Wu A, Turner K, Woolfson A, Jiang X Pharmaceutics. 2023; 15(3).

PMID: 36986819 PMC: 10053130. DOI: 10.3390/pharmaceutics15030958.

Understanding the Roles of the Hedgehog Signaling Pathway during T-Cell Lymphopoiesis and in T-Cell Acute Lymphoblastic Leukemia (T-ALL).

Martelli A, Paganelli F, Truocchio S, Palumbo C, Chiarini F, McCubrey J Int J Mol Sci. 2023; 24(3).

PMID: 36769284 PMC: 9917970. DOI: 10.3390/ijms24032962.

Mechanisms of Resistance and Implications for Treatment Strategies in Chronic Myeloid Leukaemia.

Poudel G, Tolland M, Hughes T, Pagani I Cancers (Basel). 2022; 14(14).

PMID: 35884363 PMC: 9317051. DOI: 10.3390/cancers14143300.

References

Ohlig S, Farshi P, Pickhinke U, Boom J, Hoing S, Jakuschev S . Sonic hedgehog shedding results in functional activation of the solubilized protein. Dev Cell. 2011; 20(6):764-74. DOI: 10.1016/j.devcel.2011.05.010. View

Roy S . Cilia and Hedgehog: when and how was their marriage solemnized?. Differentiation. 2011; 83(2):S43-8. DOI: 10.1016/j.diff.2011.11.010. View

Su W, Meng F, Huang L, Zheng M, Liu W, Sun H . Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through β-catenin signaling. Exp Hematol. 2012; 40(5):418-27. DOI: 10.1016/j.exphem.2012.01.003. View

Mak D, Wang R, Schober W, Konopleva M, Cortes J, Kantarjian H . Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitors. Leukemia. 2011; 26(4):788-94. PMC: 3598156. DOI: 10.1038/leu.2011.285. View

Singhal M, Sengar M, Nair R . Summary of the published Indian data on chronic myeloid leukemia. South Asian J Cancer. 2016; 5(3):162-5. PMC: 4991141. DOI: 10.4103/2278-330X.187593. View

Regl G, Kasper M, Schnidar H, Eichberger T, Neill G, Philpott M . Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2. Cancer Res. 2004; 64(21):7724-31. DOI: 10.1158/0008-5472.CAN-04-1085. View

Barnes D, Melo J . Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia. Cell Cycle. 2006; 5(24):2862-6. DOI: 10.4161/cc.5.24.3573. View

Liao H, Su Y, Zheng Z, Jhih Cai C, Hou M, Chao K . Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells. Biomed Pharmacother. 2012; 66(5):378-83. DOI: 10.1016/j.biopha.2011.12.008. View

Kanehisa M, Goto S . KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 1999; 28(1):27-30. PMC: 102409. DOI: 10.1093/nar/28.1.27. View

10.

Adams J, Cory S . The BCL-2 arbiters of apoptosis and their growing role as cancer targets. Cell Death Differ. 2017; 25(1):27-36. PMC: 5729526. DOI: 10.1038/cdd.2017.161. View

11.

Ferent J, Constable S, Gigante E, Yam P, Mariani L, Legue E . The Ciliary Protein Arl13b Functions Outside of the Primary Cilium in Shh-Mediated Axon Guidance. Cell Rep. 2019; 29(11):3356-3366.e3. PMC: 6927553. DOI: 10.1016/j.celrep.2019.11.015. View

12.

. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. Blood. 2013; 121(22):4439-42. PMC: 4190613. DOI: 10.1182/blood-2013-03-490003. View

13.

Au W, Caguioa P, Chuah C, Hsu S, Jootar S, Kim D . Chronic myeloid leukemia in Asia. Int J Hematol. 2008; 89(1):14-23. DOI: 10.1007/s12185-008-0230-0. View

14.

Kuhnl A, Gokbuget N, Stroux A, Burmeister T, Neumann M, Heesch S . High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia. Blood. 2010; 115(18):3737-44. DOI: 10.1182/blood-2009-09-241943. View

15.

Cruz C, Ribes V, Kutejova E, Cayuso J, Lawson V, Norris D . Foxj1 regulates floor plate cilia architecture and modifies the response of cells to sonic hedgehog signalling. Development. 2010; 137(24):4271-82. PMC: 2990214. DOI: 10.1242/dev.051714. View

16.

Peterman E, Prekeris R . The postmitotic midbody: Regulating polarity, stemness, and proliferation. J Cell Biol. 2019; 218(12):3903-3911. PMC: 6891101. DOI: 10.1083/jcb.201906148. View

17.

Dierks C, Beigi R, Guo G, Zirlik K, Stegert M, Manley P . Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell. 2008; 14(3):238-49. DOI: 10.1016/j.ccr.2008.08.003. View

18.

Edgar R, Domrachev M, Lash A . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001; 30(1):207-10. PMC: 99122. DOI: 10.1093/nar/30.1.207. View

19.

Jakobs P, Exner S, Schurmann S, Pickhinke U, Bandari S, Ortmann C . Scube2 enhances proteolytic Shh processing from the surface of Shh-producing cells. J Cell Sci. 2014; 127(Pt 8):1726-37. DOI: 10.1242/jcs.137695. View

20.

Venugopal N, Ghosh A, Gala H, Aloysius A, Vyas N, Dhawan J . The primary cilium dampens proliferative signaling and represses a G2/M transcriptional network in quiescent myoblasts. BMC Mol Cell Biol. 2020; 21(1):25. PMC: 7161131. DOI: 10.1186/s12860-020-00266-1. View